Back to search

Article

Identification of a gefitinib resistance-associated signature for predicting prognosis and therapeutic response in lung adenocarcinoma via integrated multi-omics analysis and machine learning

2024-07-16

Abstract excerpt

<title>Abstract</title> <p>Gefitinib resistance (GR) is widespread; therefore, alternative treatments for lung adenocarcinoma (LUAD) are needed. The study of gefitinib-resistance gene sets may lead to a better understanding of the mechanism underlying GR, methods for predicting and preventing GR, and alternative therapies. GR gene sets, single-cell data, and transcriptome data were obtained from public databases....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df9020d6-6b89-5eec-844d-eabfba49be0f
DOI
10.21203/rs.3.rs-4573455/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of a gefitinib resistance-associated signature for predicting prognosis and therapeutic response in lung adenocarcinoma via integrated multi-omics analysis and machine learningDOI 10.21203/rs.3.rs-4573455/v1
Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinationsSemantic proximity
Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse PredictionSemantic proximity
Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinomaSemantic proximity
Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosisSemantic proximity
Development of an Immune-Related Gene Pairs Signature for Predicting Clinical Outcome in Lung AdenocarcinomaSemantic proximity
Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironmentSemantic proximity
Development and Validation of a 23-Gene Signature for Prognosis Prediction in Lung AdenocarcinomaSemantic proximity
Identification of biomarkers, pathways and potential therapeutic targets for EGFR-TKI resistance in non-small-cell lung cancerSemantic proximity
Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity
Integration of single sample and population analysis for understanding immune evasion mechanisms of lung cancerSemantic proximity
Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of drugs to treat adverse reactions to immunotherapy in lung adenocarcinomaSemantic proximity
Development of a Novel Prognostic Score Combining Clinicopathologic Variables, Gene Expression and Mutationprofiles for Lung AdenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.